AMY KELLY: Open Payments
NPI 1578173555 · SUMTER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,057 in 85 payments from 17 companies in 2025. Trend: 2023 $1,313 · 2024 $1,392 · 2025 $2,057
Food & beverage: $2,022Education: $35
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $535 |
| GENZYME CORPORATION | 12 | $371 |
| GlaxoSmithKline, LLC. | 16 | $287 |
| Insmed, Inc. | 12 | $235 |
| Regeneron Healthcare Solutions, Inc. | 6 | $196 |
| Philips North America LLC | 5 | $88 |
| United Therapeutics Corporation | 3 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
| UCB, Inc. | 2 | $49 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
Products named: DUPIXENT, AIRSUPRA, Arikayce, FASENRA, TRELEGY ELLIPTA, NUCALA, Vest Therapy Und, Tyvaso.
Industry payments across SC — which companies pay providers there.
